Underwriting Focus 2019, No. 2
Issue: December 2019 | Life | Download PDF | English | Français By Mary Enslin, Life/Health Global Claims Manager, Cologne Dr. Sandra Mitic, Life/Health Chief Medical Officer, Cologne Ben Quilter, Life/Health Associate Underwriter, Cologne Anke Siebers, Life/Health Insurance Education Consultant, Cologne Annika Tiedemann, Life/Health Underwriting Manager, Cologne Prof. Dr. Christoph Pohl, St. Elisabeth Hospital and hospital of the University of Cologne
Hepatitis is a diffuse inflammation of the liver. It can take an acute or a chronic course. Acute hepatitis patients usually recover without sequelae whereas chronic hepatitis can lead to serious complications and progress to fibrosis and cirrhosis of the liver. Five different virus types A, B, C, D and E exist, but for underwriting, hepatitis B – possibly with co-infection of hepatitis D – and hepatitis C are the most relevant.
Please read in this edition of Underwriting Focus about hepatitis B and C incidence, course of infection, therapy options, prognosis and Insurance Medicine considerations. Additionally, we address the changes in the hepatitis chapter in Gen Re’s underwriting manual CLUE and include a general article on the interpretation of liver function tests. Hepatitis case studies round off the picture to prepare you for future underwriting cases.